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ABSTRACT
Patient nonadherence with medication regimen is a common problem facing health care
providers treating adult patients with Type 2 diabetes. Poor glycemic control, diabetes
related complications, and increased utilization and health care costs are among the
outcomes of poor compliance with medical regimen. Prior research indicates moderate
success with several techniques to improve medication adherence when used alone.
However, the literature suggests a need for an intervention providing a multi-component
technique, implementing self-motivating skills and follow-up prompts. Using a 15minute single exposure intervention, the current study attempted to combine these two
procedures (brief intervention including motivational interviewing with follow-up
prompts) in an attempt to increase adherent behaviors in low-income adults with type 2
diabetes. Medication adherence was measured by HbA1c, which is a biological marker
that is widely considered to be a reliable indicator of adherent behavior, as well as
pharmacy records. Results indicate nonsignificant findings for both HbA1c and
pharmacy refill measures.
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INTRODUCTION
Prevalence and Demographics in the US
The number of diagnosed cases of diabetes mellitus is showing a significant
increase in the US population. Approximately 6.2% of the population reported having
diabetes in 2000 (Centers for Disease Control (CDC), 2000). In 1999 (CDC),
approximately 450,000 deaths occurred among people with diabetes who were older than
twenty-five. The CDC estimated that diabetes was responsible for 19% of all deaths in
the United States at that time, making it the sixth leading cause of death.
Approximately 11% of adults diagnosed with diabetes take both insulin and oral
medications, 22% take insulin only, 49% take oral medications only, and 17% do not take
any medications (CDC, 1999). Diabetes cost the United States an estimated $132 billion
in 2002, $91.8 billion as a result of direct medical costs, and $40.2 billion due to indirect
costs, such as disability, work loss, and premature mortality (Hogan, Dall, & Nikolov,
2002).
Within the diabetic population, type 2 diabetes is estimated to represent 90-95%
of all cases (American Diabetes Association (ADA), 1994; CDC, 1999; Rubin & Peyrot,
2001). Factors such as race and age have been identified as placing some individuals at
greater risk of developing type 2 diabetes. African-Americans along with
Hispanic/Latino Americans, American Indians, and some Asian Americans and Pacific
Islanders are at particularly high risk. The percentages of individuals within the AfricanAmerican and Hispanic groups with diabetes are 13% and 10.2%, respectively.
With the requirement of an intricate self-care regimen, type 2 diabetes infringes
on an individual’s lifestyle, causing disruption in daily activities, and potentially financial
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strain (Andrews & Friedland, 2000; Williams, Baker, Parker, & Nurss, 1998). The
typical diabetic regimen includes increasing physical activity, weight loss, checking
blood glucose multiple times per day, and taking one or more medications. Rubin and
Peyrot (2001) describe the diabetes self-care regimen as complex, unremitting, and
unpleasant. Yet, as difficult as the self-care regimen may be for diabetics, it is inarguably
advantageous to the individual to adhere to their medical regimen. Adherence to medical
regimen encompasses several factors (e.g. diet, exercise, and self-monitoring) and
includes adherence to medication regimen. A discussion on the importance of
medication adherence and its associated factors will follow.
Adherence
Medication adherence is inarguably a crucial component to successful treatmentoutcome. Andrews and Friedland (2000, p.1) define medication adherence as “the act of
taking medications as prescribed…a highly complex clinical behavior.” Recognized as
one aspect of overall adherence to the prescribed medical regimen, optimal benefit from
medication requires more from the patient than simply following physicians’ treatment
plans. Practitioners and researchers alike recognize that patient adherence is associated
with better outcome than patient compliance.
There are many ways to be nonadherent to a prescribed medication regimen.
Examples include missing some of the prescribed doses or not taking them at all, taking
doses at the wrong time, or taking the wrong dose. Another type of medication
nonadherence is failure to follow medication instructions, such as taking medication with
or without food or water. Finally, patients may fail to adhere to their medication regimen
by not filling their prescriptions. In a study on adherence in an elderly population, 20%
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of the patients did not present their prescription to a pharmacy within one month of its
reception from a physician (Corlett, 1996).
Some researchers (Cameron & Best, 1987, Garcia & Cote, 2003) stress the
importance of making a distinction between compliance and adherence. Cameron and
Best suggest that compliance with the medical regimen concerns a more passive role
regarding the actions of the patient (e.g. taking their medication). Adherence, however,
refers to the patient’s desire to fully participate with their medical regimen, and their
positive attitude toward the regimen as well as collaboration with their health care
provider (Garcia & Cote, 2003). For the current paper, we choose to use the term
“adherence”, although we recognize that adherence and compliance are often used
interchangeably.
Methods for Assessing Patients’ Adherence
Assessing patients’ level of adherence, although difficult by any measure, can be
considered to exist on a continuum. On one end of the spectrum are the “direct” or
biological markers such as HbA1c for diabetics or urine analysis. On the other end of the
spectrum are the “indirect” modes for obtaining information such as self-report and
pharmacy data. Some argue that there is no definitive method, and advocate using
multiple measures to assess patients’ adherence. Methods for measuring adherence
include biological markers, electronic monitoring, pill counts, pharmacy data, self-report,
and daily medication diaries.
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Biological Markers
Biological markers of adherence refer to physiological representations of a
patient’s adherence through blood or urine samples. For diabetics, HbA1c is considered
to be the most reliable biological measure for collecting adherence data, and arguably the
most reliable measure overall. This measure involves taking a blood sample, and allows
health care providers to assess patients’ levels of adherence for approximately the past
three months (Kavanagh, Gooley, & Wilson, 1993). The blood sample allows health care
providers to assess adherence by examining the amount of oxygen-carrying red blood
protein, with glucose tightly bound to it. When a patient has not been following their
medical regimen, HbA1c blood level will be elevated (Thomas, 1989).
Electronic Monitoring
A relatively new indirect method for obtaining adherence information is
electronic pill monitoring. Next to biological markers, this method is considered to
provide the most reliable information (Wagner, 2002). With this method, an electronic
device is inserted into the cap of the prescription bottle. This device records the date and
time of bottle opening. Health care practitioners can then download the electronic
information for their records (Cramer, 1995). One drawback of this method is that it is
unable to record the number of pills taken from the bottle at each time that it was opened.
Electronic monitoring is also reported to be a costly measure of adherence (Andrews &
Friedland, 2000).
Pill Counts
This method for measuring adherence requires that the patient return to clinic
after a specified amount of time and bring with them their medications for their health

4

care practitioner to count. Cramer (1995) identifies problems with this methodology as
not being able to use the data to assess for patients’ adherence to time and dosage (e.g.
not taking their medications at the prescribed time, or not taking the recommended
dosages). The health care practitioner must also be aware that the patient can simply
discard a specific amount of their medication before their appointment to make it appear
that they took all their recommended dosages. Haynes, Wang, and Gomes (1987) suggest
that medication adherence using pill counts can be increased by special pill packaging,
with specific medication taking instructions placed on the package.
Pharmacy Data
Among other adherence measures are prescription fill and refill data obtained
from pharmacies (Miller, Hill, Kottke, & Ockene, 1997). Pharmacy data can be used to
assess adherence by knowing the frequency with which the medication needs to be filled,
then comparing that information with the actual frequency that the prescription was
filled. The researcher then infers, for example, that if the patient has not been to the
pharmacy to refill their prescription, they have not been adhering to their medication
regimen. Paes, Bakker, and Soe-Agnie (1997) found pharmacy data to be useful in
examining overall patient medication adherence, and also adherence when comparing
different dosing frequencies.
Self-Report
Another indirect way to assess for level of adherence to a medical regimen is to
use self-report measures. Patient self-report involves the health care provider asking the
patient to recall their medication taking practices from appointment to appointment.
Many researchers and practitioners report that this method of obtaining adherence

5

information results in patient overestimation of adherence (Wagner, 2002). Cramer
(1995) reported that this overestimation might be the result of patients telling their health
care practitioners what they think their health care practitioner wants to hear. Andrews
and Friedland (2000) reported that self-report is more accurate with assessing poor
adherence than good adherence. Regardless, this method allows health care providers to
get a rough estimate of their patients’ adherence.
Daily Medication Diaries
Daily medication diaries are considered to be another form of self-report. With
this method, the patient records their medication taking activities. In their 1984 study,
Pederson, McLean, and Millingen used medication diaries that consisted of check marks
placed by medications taken daily. Wagner (2002) reports that this method is associated
with patient overestimations of adherence, and produces reliability of information similar
to the standard self-report method.
Both direct and indirect measures of adherence are used to examine patient
medication taking practices. There is a body of literature to support the benefit of using
more than one method to examine medication adherence (Becker, Glanz, Sobel, Mossey,
Zinn, & Mott, 1986; Pederson, McLean, & Millingen, 1984; Williams, Rodin, Ryan,
Grolnick, & Deci, 1998).
Factors Pertaining to Adherence
There are many variables that have been associated with patient adherence to their
medication regimen. Amongst those factors are psychosocial factors, economic factors,
patient knowledge, and motivation.
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Psychosocial Factors
Several psychosocial factors have been found to correlate with adherence to
medication regimens. These include depression, stress, anxiety, social support, barriers
and health beliefs, patient characteristics, economic factors, patient knowledge, and
patient motivation.
Depression. Depression is one factor that has been found to negatively influence
diabetic medication adherence (Ciechanowski, Katon, & Russo, 2000; Lustman, Griffith,
& Clouse, 1997), and may contribute to decreased levels in glycosylated hemoglobin, a
biological marker commonly known as HbA1c. Depression may attenuate medication
adherence by inhibiting motivation and general self-care in individuals (Lustman,
Griffith, & Clouse, 1997; Richardson, 2003).
Anxiety, Stress, and Social Support. In addition, stress (Shobhana, Begum,
Snehalatha, Vijay, & Ramachandran, 1999), anxiety (Brownbridge & Fielding, 1994) and
social support (Golin, DiMatteo, & Gelberg, 1996; Power et al., 2003) have been
identified as factors impacting adherence for individuals with various chronic illnesses.
Peyrot, McMurry, and Kruger (1999) report that it is important to address psychosocial
issues, as there is a correlation with diabetics, between increased stress and decreased
glycemic control.
Barriers and Health Beliefs. Positive health beliefs regarding adherence to
medication taking have been found to be associated with good medication adherence
(Garcia & Cote, 2003; Golin, DiMatteo, & Gelberg, 1996; Malcolm, Ng, Rosen, & Stone,
2003). Decreases in patients’ numbers of perceived barriers have also been identified as
contributing to patient adherence (Bond & Hussar, 1991; Miller et al., 1997; Paes,
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Bakker, & Soe-Agnie, 1997; Rubin & Peyrot, 2001; Williams, Rodin, Ryan, Grolnick, &
Deci, 1998).
Pertaining to diabetics, treatment-related barriers and negative emotions
contribute to lack of success in reducing HbA1c (Weinger & Jacobson, 2001). The
authors suggest that problems with adherence are cyclical in that poor adherence may
lead to poor glycemic control, which creates treatment-oriented frustration (for the patient
and the health care provider). This cycle perpetuates itself while creating greater
problems with glycemic control and adherence.
Patient Characteristics. Research suggests that specific characteristics may put
certain patients at-risk for nonadherence. Such characteristics include: younger age
(Aljasem, Peyrot, Wissow, & Rubin, 2001; Power et al., 2003), minority status, primarily
African-American (Aljasem, Peyrot, Wissow, & Rubin, 2001; Golin, DiMatteo, &
Gelberg, 1996; Schectman, Bovbjerg, & Voss, 2002; Snodgrass, Vedanarayanan, Parker,
& Parks, 2001), and lower levels of education (Power et al., 2003; Shobhana, Begum,
Snehalatha, Vijay, & Ramachandran, 1999).
Economic Factors. There is some evidence that the economic cost associated
with medication taking influences patient adherence. In their study, Mojtabai and Olfson
(2003) report that in 2000, more than two million Americans receiving Medicare suffered
cost-related problems with their medication adherence. They reported that many patients
knowingly miss doses, take lower doses than prescribed, or fail to refill their
prescriptions due to the associated costs. There is research to suggest that individuals of
low socio-economic status (SES), have an increased risk for medication nonadherence
(Apter, Reisine, Affleck, Barrows, & Zuwallack, 1998; Brownbridge & Fielding, 1994;
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Schectman, Bovbjerg, & Voss, 2002; Shobhana, Begum, Snehalatha, Vijay, &
Ramachandran, 1999), as not being able to afford their medications may contribute to
patients’ nonadherence. Snodgrass, Vedanarayanan, Parker, and Parks (2001) found
decreased adherence in populations where patients have applied for Supplemental
Security Income.
Patient Knowledge. Corlett (1996) suggests that two primary reasons for
medication nonadherence are lack of knowledge regarding medication administration and
failure to appreciate the importance of drug treatment in the management of the disease.
Although no strong correlations between medication adherence and patient knowledge
have been found to exist, many researchers and practitioners believe that patient
education is still an important component of the treatment plan (Golin, DiMatteo, &
Gelberg, 1996; Peck & King, 1982; Rubin & Peyrot, 2001; Shobhana, Begum,
Snehalatha, Vijay, & Ramachandran, 1999).
Patient Motivation. Patient motivation has been identified as having a strong
influence on adherence to medication regimens (Garcia & Cote, 2003; Peck & King,
1982). Models have been proposed that attempt to correlate stages of motivation with
patient adherence (i.e. Prochaska and DiClemente’s Transtheoretical Model). This
research has been replicated by Trigwell, Grant, and House (1997), who found that
patients’ current stage of change was correlated with HbA1c measures in a population of
361 diabetics.
Pertaining to motivation to adhere to treatment recommendations, patient attrition
is also considered to be a factor predisposing patients to medication nonadherence.
Research has identified high attrition as a problem for providing interventions, especially
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in the low SES African-American population (Rimmer, Silverman, Braunschweig,
Quinn, & Liu, 2002). The authors identified treatment cost, transportation, and time as
variables contributing to attrition. Given the high attrition in the low SES AfricanAmerican population, a one-session treatment intervention is appealing. Healthcare
providers should attempt to motivate their patients to attend their appointments to
increase the likelihood that they will be adherent to their rest of their treatment plan.
Theoretical Explanations for Adherence/Nonadherence
Health Belief Model
Created by Hochbaum, Leventhal, Kegeles, and Rosenstock (1966), the health
belief model (HBM) suggests individuals behave or adhere based on their readiness to act
in such a way that would reduce the severity of their condition (Maiman & Becker,
1974). However, this action is based, in part, on their attitudes or beliefs regarding their
perceived susceptibility or vulnerability. In fact, HBM suggests that the individual’s
perception of reality has greater value than the actual reality concerning behavior change
(Hurley, 1990).
According to HBM, behavior change requires three steps. The first step is the
assessment of an individual’s readiness for behavior change. The second step involves
weighing the pros and cons for behavior, after the individual has acquired enough
information to understand what the behavior modification will entail. Lastly, internal
and/or external cues are developed which serve to prompt the individual to initiate
behavior change (Bloom Cerkoney & Hart, 1980).
In health care settings, patients weigh the recommendations of their health care
provider against their estimations of the potential outcomes of both adherence and non-
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adherence. Concerning the relationship between HBM and decision making, HBM states
that motivation, both internal and external is necessary to produce change, but requires
significant endorsement of the procedure required to produce the change (Maiman &
Becker, 1974; Streecher, Champion, & Rosenstock, 1997).
Positive correlations exist between patients’ adherence and their health beliefs
(Becker, Maiman, Kirscht, Haefner, Drachman, & Taylor, 1979). It has been suggested
that health beliefs have a causal relationship with adherence. Becker et al. also suggest
that by addressing patients’ perceptions about their illness and treatment regimens,
physicians may potentially be able to predict their patients’ level of adherence.
Therefore, to improve adherence, they recommend implementing strategies to modify
current maladaptive health beliefs and perceptions by addressing patient’s attitudes
regarding their illness and current regimens.
Rosenstock (1975) outlines six characteristics that contribute to a person’s
adherence. The first characteristic is patient motivation (i.e. the patient must be aware of
their health and interested in improving their behaviors). The second characteristic is the
patient’s perceived susceptibility to a particular illness. The patient must be aware that
they are vulnerable to the particular issue of concern. Third, the patient must have a
certain perceived severity. This means that they realize that, depending on their actions,
their illness will impact them in a certain way. Perceived benefits of professional
intervention is the fourth characteristic. The patient must believe that their illness will
improve if they choose to adhere to their prescribed medical regimen. The fifth
characteristic is the patient’s perceived barriers to taking action. It is important that the
patient believe that the benefits of changing their behavior outweigh the costs of their
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behavior staying the same. Lastly, the patient must consider knowledge of the medical
condition and prescribed regimen to be important (e.g. what their medications are, why
they need to adhere to their medical regimen, and the specific behaviors to be performed
in order to adhere to their medical regimen).
After a review of the current literature on disease models and their applicability in
explaining the various influences which contribute to adherence in diabetic patients,
Gentili, Maldonato, Grieco, and Santini (2001) asserted that the health belief model is
particularly applicable to adherence issues in individuals with diabetes. They asserted
that health care providers must not only provide direct treatment interventions, but they
must also address patients’ concerns and potential barriers to adherence regarding their
medication regimens.
Transtheoretical Model
The transtheoretical model seeks to integrate several existing models. In addition,
Prochaska et al. (1994) concluded from their study using 3,858 patients with one of 12
problem behaviors (i.e. cocaine use, failure to have mammography screenings, condom
use, etc.), that the transtheoretical model was highly effective in promoting positive
health behaviors when paired with other models. It is regarded as an eclectic approach to
psychotherapy (Prochaska & Norcross, 1999). This model attempts to preserve and
combine major principles that are considered effective in behavior change by
encouraging treatment programs to be creative and tailored.
One way in which this is done is by addressing patients’ individual needs.
Patients have unique variables that contribute to or impair their ability to adhere to their
medication regimen (e.g. adapting their medication regimen to their particular schedule).
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Utilizing processes of change, which are behaviors performed by individuals to change
their thinking and behavior, is another principle that is integrated into the transtheoretical
model. Stages of change, which are attitudes at any given time about change, can also be
an effective tool used from within the transtheoretical framework to get patients to
become more aware of where they are in terms of readiness to make behavior
modifications. Lastly, motivational interviewing, a brief, directive, client-centered
approach that brings about behavior change through dealing with ambivalence to change,
is an effective technique to move patients through the stages of change by incorporating
processes of change to prompt individuals to become more active in their behavioral
conduct.
In essence, this model suggests that tailoring to individual needs will be achieved
by matching the individual’s process of change with their stage of change. Norcross,
Prochaska and DiClemente (1995) (as cited in Prochaska & Norcross, 1999) report that
this can easily be accomplished using some of the techniques outlined by Miller and
Rollnick’s motivational interviewing. Processes of change involve the actions that
people perform to modify their behavior. The stages of change are a theoretical measure
of where the patient is regarding their attitudes about behavior change. These include
precontemplation where the patient is not thinking about behavior change, contemplation
where the patient begins to think about behavior change, and preparation where the
patient prepares to make the behavior change. Once they begin behavior modifications,
they are in the action stage. Lastly, in order to sustain the modifications that they have
made, patients go into the maintenance phase, where one of the focuses is relapse
prevention.

13

Prochaska, DiClemente, and Norcross (1992) state that to increase the likelihood
that individuals will chose to decrease their maladaptive behaviors, in addition to
addressing patients’ attitudes regarding behavior modification, interventions (i.e.
processes of change) that are behaviorally focused must be incorporated into individuals’
self-management regimens. They found that the processes of change, which produced
the most significant results, were the more behavioral change processes (i.e.
counterconditioning where the patient substitutes alternatives for problem behaviors). In
other words, patients’ treatment must depend on the matching of their stage of change
(e.g. precontemplation, contemplation, preparation, action, or maintenance) with the
appropriate process of change.
Increasing Adherence
As previously discussed, medication adherence is becoming an increasing
problem for persons with type 2 diabetes in the United States. Many methods exist for
assessing medication adherence. Likewise, there are several known factors that influence
medication adherence. Thus, researchers and practitioners must use this information to
create interventions that will improve medication adherence. When developing an
intervention, considerations for the intervention include: how many components to
include in the intervention, certain design components, and the degree of interpersonal
involvement with the health care practitioner to be included.
Applicability of Multi-Component Intervention Designs
When attempting to increase medication adherence, deciding how many
interventions to implement is an important consideration. Single interventions have been
used historically, yielding mild to moderate effects. Currently, more multi-component
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interventions are used to maximize treatment effectiveness. Single interventions that
have been used in the past are often combined with one another to enhance the
intervention. These single interventions can be behavioral, psychosocial, or a
combination of the two.
Single Interventions
In an early review of the literature, Haynes, Wang, and Gomes (1987) stated that
there were no known single interventions with significant long-term effects on adherence.
Examples of single interventions include self-monitoring (Baker & Kirschenbaum, 1993;
Edmonds et al., 1985), counseling by health care practitioners (Levine, et al., 1979),
special unit dose reminder pill packaging (Becker et al., 1986), phone follow-ups (Taylor,
Houston-Miller, Killen, & DeBusk, 1990), patient education (Morisky et al., 1983), and
tailoring (Prochaska, DiClemente, Velicer, & Rossi, 1993; Rimer et al., 1999). Haynes et
al. suggest that many of the treatments that have been tried alone may yield positive
results when linked with one another. In a more recent review, Miller et al. (1997)
arrived at a similar conclusion.
Combining Behavioral Interventions
Several studies support that medication adherence can be enhanced by combining
single interventions. These combinations can occur as behavioral strategies only, or in
tandem with psychosocial interventions. Takala, Niemela, Rosti, and Sievers (1979)
found an increase in adherence to blood pressure medication by using combinations of
single-interventions that were strictly behavioral. Those interventions included oral and
written instructions regarding medication regimens, a follow-up card with blood pressure
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readings, medications prescribed, and the time of the next appointment, as compared to
the control group, which received only oral instructions.
The findings of Skaer, Sclar, Markowski, and Won (1993) suggest that multiple
behavioral interventions improve medication adherence. In addition, they found a
positive correlation between increased adherence and the number of behavioral strategies
that were implemented. In addition, the groups receiving multiple interventions obtained
significant results regarding reduction in physician, laboratory, and hospital service
utilization, as compared to the single intervention and usual care groups.
Combining Behavioral and Psychosocial Interventions
There is support to suggest that multiple interventions are even more effective
when psychosocial interventions are implemented along with behavioral interventions.
Cramer (1995) outlines four strategies (i.e., education, planning of dosing regimens,
improved communication, and clinic visits) that may produce more significant results
when paired with one another. Education that involves both the patient and their family
has been tested. Likewise, the planning of dosing regimens by using a pill box or the use
of checklists for medication times has been researched. Cramer emphasizes the
importance of strong communication between the health care provider and the patient,
including a discussion of the diagnosis and treatment plans. Lastly, the scheduling of
clinic visits can be adjusted to minimize waiting times as well as scheduling more
frequent visits. The author reported that adherence improves by 10% five days before a
physician visit; therefore, more frequent appointments can also improve patient
adherence.
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There is support in the literature for the efficacy of using patient counseling to
increase patient motivation for medication adherence as a component of the intervention
(Morisky et al., 1990; Pederson, McLean, & Millingen, 1984). These psychosocial
interventions can be used to increase patients’ knowledge about their medications and
address barriers to medication taking.
Peyrot, McMurry, and Kruger (1999) report that multicomponent approaches
should include patient training and improved management of psychosocial issues. They
assert a direct relationship between medication adherence and psychological health.
They suggest that with people with diabetes, stress and coping impact metabolic control
through psychological (i.e. patients having difficulty with adherence while managing
stressors of their daily lives) and physiological (i.e. the increase of hepatic production of
glucose as a reaction to the release of hormones that respond to stress) processes.
Therefore, it appears that better management of psychosocial issues pertaining to daily
living is more conducive to patient adherence with their medical regimen.
Design Considerations for Adherence Interventions
Once the interventions to be used have been decided upon, researchers must
determine how they will be implemented. There are several considerations to keep in
mind when creating an intervention plan. They are time, cost, simplicity, brevity, and
demographic tailoring.
Time
In medical settings, interventions are designed to be effective relative to time and
cost efficiency. It is important that interventions be provided in as little time as possible
for medical staff efficiency. Current attempts to achieve this goal are being explored by
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health care providers in order to move towards brief assessments that use computer
technology, and assessments and interventions provided to the patient by individuals
other than the patients’ immediate medical staff (Glasgow & Eakin, 1998).
Cost
In addition to time efficiency, Glasgow and Eakin (1998) also showed that low
cost measures for encouraging adherence are becoming more widespread.
Recommended strategies include 1) the use of low-cost reminders to patients regarding
appointments and medication refills, 2) physician reminders regarding the importance of
adherence, and 3) referrals to other health care professionals who can assist the current
medical team in providing services and enhancing adherence with the medical regimen.
Simplicity
It appears that successful interventions are not necessarily complex interventions.
In their research on improving self-management in persons with diabetes and effective
methods for training health care workers to assist patients, Doherty, Hall, James, Roberts,
and Simpson (2000) concluded that it may be more effective for a medical team to begin
with a minimal amount of sub-components of change as opposed to attempting to
promote behavior change using more complex interventions. Although this may not
necessarily be ideal in that the practitioner would be addressing fewer problems at one
time, it may be simply more practical. It may also be easier to train a staff to complete a
small portion of an intervention at one time. Trainers can teach the staff at a more basic
level, requiring less training. Based on their findings, Doherty et al. concluded that
training interviewers is best when kept simple (i.e. fewer components in the intervention).
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Brevity
In addition, especially when an intervention involves more than one interviewer,
it is best to condense the sessions with patients to primary skills because the interventions
will be easier to teach and reliability will most likely be higher. Doherty et al. (2000)
reasoned that the more brief an intervention, the easier it is to instigate it in multiple
health care settings with multiple trainers. They also concluded that the techniques for
behavioral modification (which present the same factors in motivational interviewing) are
easily taught to potential trainers as well as easily received by patients.
Miller and Rollnick (2002) state that brief interventions of one to three sessions
are as effective as more extensive treatments. They point out that brief interventions,
using the principles of motivational interviewing, are more beneficial to the patient than
no treatment at all. Other studies have asserted that by using brief motivational
interviewing, patients can be influenced to change within a matter of minutes (Resnicow,
DiIorio, Borrelli, & Hecht, 2002).
Demographic Tailoring
In designing effective interventions, health care providers would benefit from
considering the particular population for which they are designing the intervention. The
results of a study by Brantley et al. (1999) suggest that preventative programs must be
created for patients with special tailoring, based on their targeted racial, gender, and/or
age groups. Their research regarded prevalence of risk behaviors (e.g. smoking, high
dietary fat, and sedentary lifestyle) in a predominantly African-American, low SES
population. Thus, in a low SES, African-American population, race and ethnicity and
SES should be considered when designing and intervention. For example, for such a
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population, transportation difficulties and the need for a low cost intervention should be
considered.
Patient-Centered Multicomponent Interventions Targeting Motivation
When designing an intervention aimed at behavior change, a baseline measure
concerning the individual’s current activities and motivation to change should be
acquired. Part of this assessment involves evaluating the degree to which patients are
considering making behavioral changes. Individuals who spend less time thinking about
behavior change are less likely to re-evaluate their current behaviors (Prochaska &
DiClemente, 1983). Included in the evaluation of motivation for change, are the
identification of past attempts for behavior change, and the variables contributing to
success or failure (Hoppe, Farquhar, Stoffelmayr, & Helfer, 1988). Research has
examined the effects of counseling and conducting interpersonal interviews with patients
in an attempt to enhance their motivation towards adherence. Miller and Rollnick (1991)
have developed a brief intervention (Motivational Interviewing) that can be used to help
motivate individuals to change maladaptive behaviors.
Brief Counseling
In a study on smoking cessation, patients in a primary care setting who received
brief patient-centered, behavior-oriented counseling were more likely to change their
behaviors and move towards smoking cessation than participants who were only provided
brief advice to stop smoking (Ockene et al., 1991). This type of counseling is used to
promote patient involvement in behavior change, and addresses many of the same issues
as motivational interviewing. The subjects were divided into three groups with the first
group receiving only advice to stop smoking. The second group received the advice as
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well as a counseling intervention that covered five areas: motivation to change, past
experiences with attempting to modify the behavior, current concerns, resources available
to assist the patient in making the change, and interest in developing a plan for changing
the behavior. The third group was provided the advice, the counseling intervention, and
nicotine-containing gum (NCG). The NCG group was the most successful. Their
findings suggested that this group was twice as likely as those in the advice only group to
abstain from smoking for three months. The counseling group was 1.6 times more likely
than the advice only group to abstain from smoking for three months. Thus, the
researchers concluded that the brief patient-centered intervention was more effective
because it reduced defensiveness and supported the patient-health care provider
relationship.
Motivational Interviewing
Rollnick (2002) identifies the “spirit” of motivational interviewing (MI) as the use
of exploration as opposed to exhortation, and support rather than persuasion and
argumentation, as methods for creating an environment for behavior change. Using core
techniques of MI, including reflective listening, rolling with resistance, agenda setting,
and increasing self-motivation, has shown that motivational interviewing can be useful in
a variety of settings and across different populations (Miller & Rollnick, 1991).
Reflective listening is designed to promote patient rapport. The primary goal is to
communicate to the patient acceptance of them, regardless of their stage of change or
current maladaptive behaviors. Employing empathy and reflectively listening will help
the interviewer establish a better picture of the patient’s current situation. Rolling with
resistance is a technique for discussing with the patient potential consequences and
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outcomes of behavior change, without debating with them or arguing. The interviewer
introduces new perspectives and potential solutions without demanding that the patient
implement them. Instead, the patient’s ideas can be considered and incorporated into the
treatment plan. Agenda setting promotes patient action and provides direction for the
client as well as the interviewer. Lastly, supporting patient self-efficacy will place the
decision-making and implementing behavior change on the patient. It will be the
patients’ belief in themselves that will ultimately lead to successful outcomes.
Motivational Interviewing and Adherence. Motivational interviewing, as it
attempts to increase patient autonomy and self-management as well as self-efficacy, has
been identified as having the potential to increase adherence in primary medical settings
because of its potential brevity (Noonen & Moyers, 1997). More specifically, MI may
potentially increase adherence with medical regimen in adults with diabetes (Clark &
Hampson, 2001; Senecal, Nouwen, & White, 2000; Stott, Rees, Rollnick, Pill, & Hackett,
1996), and adults with psychosis (Kemp, Kirov, Hayward, & David,1998).
Motivational Interviewing in Clinical Settings. Looking to the future,
motivational interviewing has the potential to be provided on a regular basis in diabetes
clinics. In order for this to be efficient, motivational interviewing will have to be taught
to medical teams, which may include members other than physicians and psychologists.
Concerning the training of others to provide interventions to promote behavior change,
Resnicow, DiIorio, Borrelli, and Hecht (2002) stated that a strength of motivational
interviewing is that it can be used effectively after minimal training not only by
psychologists, but by other members of the health care profession as well. But
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ultimately, it is imperative that the intervention be created so that one or more members
of the medical team can learn to provide it to patients.
Motivational Interviewing and Potential Implications. Noonen and Moyer (1997)
in their review of MI research to date suggest that several variables should be examined
in future research using motivational interviewing. They suggest that MI be used with
populations that are in a position to be receiving advice from health care professionals,
and to have their motivation to comply with the information that has been provided to
them examined. In addition, the length of the intervention to achieve maximum
effectiveness has remained unclear. This information is especially important in medical
settings where interactions between the medical staff and their patients can be very
limited. Lastly, researchers have suggested that MI may not be appropriate for all
populations. Examining effectiveness in a low income, predominantly African American
population may provide further insight.
In summary, diabetes is a medical condition of growing concern for the U.S.
population. Two theoretical models have been proposed to address adherence and
nonadherence. Adherence to the diabetic medication regimen is a factor of concern for
physicians and may be measured in a variety of ways, such as HbA1c and self-report.
Research indicates that multi-component designs to improve adherence are more
effective than single component experiments. It appears that principles of motivational
interviewing, when provided in brief and concise sessions, have the ability to produce
behavior change in patients with diabetes, especially when paired with other techniques,
such as the use of follow-up prompts.
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The purpose of the present study was to examine whether a brief intervention
using the core principles of motivational interviewing and a follow-up prompt would be
associated with greater patient adherence with medication than usual care in a low
income, predominantly African-American population. Adherence to the medication
regimen was determined by analyses of serum HbA1c, an indicator of adherence over 2-3
months, and pharmacy records of patient medication refills.
Hypotheses
1. It was hypothesized that patients receiving motivational interviewing and a
follow-up prompt (Treatment Group) would show a significant improvement in
adherence, as indicated by a decrease in HbA1c levels, as compared to a group
receiving usual care (Control Group).
2. It was hypothesized that patients receiving motivational interviewing and the
follow-up prompt (Treatment Group) would evidence higher percentages of
diabetic medication prescription refills as compared to those receiving usual care
(Control Group).
3. Individual differences among patients in the Treatment Group (i.e. age, race,
marital status, etc.) were examined to determine potential predictors of adherence
to medication regimen. No hypotheses were proposed.
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METHOD
Participants
Participants were recruited from the Diabetes Clinic at Earl K. Long Medical
Center (EKL). Adults with type 2 diabetes who were currently taking diabetic
medication were approached for participation in this study. Patients were excluded from
this study if they had been diagnosed with Type I diabetes, were not currently medicated
for diabetes, not able to provide an address where they would be residing for three
months after the initial assessment, or if their oral comprehension was below the 5th grade
level as determined by the Woodcock Johnson-Oral Comprehension test (Woodcock,
McCrew, & Mather 2001). Patients were also excluded if they were determined to be
depressed, as measured by the Beck Depression Inventory-PC (Beck, Guth, Steer, & Ball,
1997). Depressed patients were offered a referral to the Adult Psychology Department.
Measures
Demographic Questionnaire
A self-report demographics questionnaire was administered to participants. This
questionnaire included: name, hospital number, date of diagnosis of diabetes, date of
birth, sex, age, race, marital status, education level, employment status, current
medications, location of prescription refill, and the frequency with which they have been
instructed to take their medication(s) (See Appendix A).
Woodcock-Johnson-Oral Comprehension
The Woodcock-Johnson III-Test of Achievement (Woodcock, McCrew, &
Mather, 2001) was used to ensure that the patients understood the conversation and
instructions that were given to them during the brief intervention. This test has been
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shown to have a reliability coefficient of .89 for adults. In order to participate in this
study participants had to demonstrate that they have at least a 5th grade oral
comprehension level. The suggested starting point for grade 5 is Item 13. For this study,
questions began with Item 7, which is a grade 3 to 4 comprehension level. Patients were
required to answer items 7-13 correctly to participate. Patients who failed to pass this test
were not permitted to participate in this study.
Beck Depression Inventory-PC
The Beck Depression Inventory for Primary Care (BDI-PC) (Beck, Guth, Steer, &
Ball, 1997) is an abbreviated version of the original BDI and consists of seven items.
Steer, Cavalieri, Leonard, and Beck (1999) used the BDI-PC to screen outpatients with
more chronic and comorbid medical diagnoses. Their results indicated a mean score of
6.55 for the patients who were diagnosed with Major Depressive Disorder. They suggest
a cutoff score of 5 to 6 and above to minimize the potential of falsely classifying a
nondepressed person as being depressed.
HbA1c as a Biological Marker of Adherence
Patients’ adherence to their medication regimen was determined by measuring
their glycosylated hemoglobin levels (HbA1c). This measure is widely accepted as an
outcome measure of a patient’s adherence to their medical regimen over a 2-3 months
period (Peyrot, McMurry, & Kruger, 1999; Goldstein et al., 1982). HbA1c reports the
amount of oxygen-carrying red blood protein that has glucose tightly bound to it. It
provides a measure of average blood concentration of the glucose (Kavanagh, Gooley, &
Wilson, 1993). The normal range of HbA1c is 4-6% in individuals without diabetes. In
individuals with diabetes, an acceptable range is generally considered to be between 4
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and 8%. The range for most nondiabetics is between 5.4% and 7.4% (Hurley, 1990). At
Earl K. Long, patients’ HbA1c levels are measured approximately every three months
during their regularly scheduled visits to the Diabetes Clinic. Patient HbA1cs were
obtained from their medical charts.
Procedure
The primary investigator identified which patients were attending the diabetic
clinic for a routine 3-month follow-up visit and approached them for participation in this
study. If the patient met the demographic requirements for participation, the study was
explained, including time commitment and the possibility of receiving a follow-up letter.
A form (See Appendix B) requiring their consent to participate was presented and
confidentiality was explained. The consent form informed participants that their address
would be documented, their medical chart would be examined, and their HbA1c levels
would be recorded. Participants were also provided with the experimenters’ contact
information should they have further questions or wish to know the results of the study.
After they were placed in a physician’s examining room, the Woodcock Johnson was
administered. If patients failed to pass the 5th grade level of the oral comprehension
subtest of the Woodcock-Johnson, they were thanked for their time and their participation
in this study was terminated. Patients that passed the oral comprehension test were given
the BDI-PC. Individuals who scored a 6 or above on the BDI-PC were excluded from
participation. Those that endorsed suicidal ideation on item 6 were assessed for suicide
potential. The appropriate referrals were made for these patients to receive further
assessment and possible treatment.
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Eligible patients were randomly assigned to the experimental or control group
using a random numbers table. A brief, structured (See Appendix C), approximately 15minute intervention was performed with participants assigned to the experimental group,
and included a discussion of the importance of taking their medications, activity
management (i.e. incorporating medication taking into one’s daily routine), anchoring
medication use (i.e. taking medication at the same time every day), using cues and
reminders (i.e. placing bottles that need refilled near keys where they can be a reminder
to have refilled), the use of self-monitoring, and self-reinforcement. The investigator
attempted to discuss with the patient the feasibility that they could make the behavior
changes necessary to become more adherent with their medication regimen. Barriers to
adherence with medication regimen were addressed and the patient was encouraged to
problem-solve with the investigator. Following the interview, patients were given a
handout that provided them with ideas to help them remember to take their medications
and to refill their prescriptions, as well as to motivate them to become more active in
their diabetes management and discuss their diabetes with their physician (See Appendix
D).
Patients randomly assigned to the control group were given usual care. They
were asked a few questions about their current medication regimen (See Appendix E).
This assisted the researcher in developing a baseline measure of their adherence, as well
as controlling for exposure to the researchers. They were then thanked for their time and
the session was terminated.
One week following the interview, the investigator sent a reminder letter to the
experimental group, reminding them that they needed to refill their prescriptions and that
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they should attend their follow-up appointment in two months. They received one of
these letters each of the three months until their next scheduled appointment. For both of
the groups, HbA1c levels were extracted from the medical charts of the participants
following their next lab visit. If patients failed to attend the diabetes clinic within six
months, they were excluded from the study. Patients attending the Diabetes Clinic are
scheduled in 3-month intervals at which time they are given blood tests, and measures of
HbA1c levels are recorded. Therefore, barring failure to attend a scheduled appointment,
HbA1c levels were available for the date that the intervention was administered, as well
as upon their three and/or six month follow-up appointment.
The brief intervention was delivered by the author, Kathleen Kendra, a graduate
student in the doctoral clinical psychology program at Louisiana State University-Baton
Rouge. In addition to reviewing the literature on motivational interviewing, a brief
manual, which outlines the basic principles of motivational interviewing (See Appendix
F) was created for purposes of synthesis of information and review.
Independent Variables
1. Treatment versus usual care.
Dependent Variables
The outcome variable to be ascertained was adherence to medication regimen,
which was assessed by conducting chart and medication record reviews.
1. HbA1c: This measure was obtained from the medical charts of each of the
participants. It was acquired by recording the results of the patient’s blood
tests following the three-month treatment period.
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2. Percentage of medication refills: Many of the patients at Earl K. Long
Memorial Hospital have their diabetes medication prescription(s) filled at the
EKL pharmacy. Records were obtained for each participant as to whether or
not they had their prescriptions filled each month following their enrollment
in the current study. Results were recorded as the percentage of refills
prescribed following the onset of participation in this study.
Estimated Sample Size
Based on previous studies, in which findings reported a .8 improvement in HbA1c
at best, the effect size was set at -.8. Setting the effect size at -.8 suggested that 70
participants in each group were needed to achieve a power level of .80. A total of 140
subjects were desired.
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RESULTS
Descriptive Data
A total of 157 participants were invited to participate in this study. Eight subjects
who were approached elected not to participate. Ten participants of the 157 initial
subjects were excluded because they had not had an HbA1c measure in at least the past
three months. In addition, 7 subjects were excluded for not meeting the WoodcockJohnson 5th grade level requirement and/or scoring above a 5 on the BDI-PC. One
hundred and forty individuals entered the study. Thirty-three of those 140 individuals
could not complete the study, as they either did not return or were not scheduled by their
physician for follow-up lab work within six months. A total of 107 individuals
completed the study.
The average years of diabetes diagnosis for the 107 participants was 10.27 years.
The sample was predominantly female (81.8%), and African American (83.3%).
Participants were more likely to be married (35.4%) or single (29.3%). Approximately
83.5% percent had a high school degree or GED equivalent. The vast majority of
participants were currently unemployed (76.8%). No subjects endorsing suicidal ideation
on the BDI-PC endorsed plan or intent.
Prior to testing the study hypotheses, descriptive statistics (e.g., means and
standard deviations) were obtained on all experimental variables (i.e., demographic
variables, HbA1c, pharmacy refill data) (See Table 1). A two-sample nonparametric test
was conducted to determine whether the Treatment Group differed demographically (i.e.,
marital status, sex, and ethnicity) from the Control Group. No significant differences
were found between the groups for marital status χ2(1, N = 107) = 1192.5, p > .05, sex
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χ2(1, N = 107) = 1151.5, p > .05, or ethnicity χ2(1, N = 107) = 989.5, p > .05. One tailed
t-tests revealed no significant differences between groups for age, t (105) = .571, p > .05,
years diagnosed, t (104) = .637, p > .05, education, t (104) = .661, p > .05, or BDI score t
(105)= .264, p> .05.
Table1
Means and standard deviations of experimental variables for control and experimental
groups. N=107
_______________________________________________________________________
Variable
Experimental n=50
Control n=57
Mean
SD
Mean
SD
Years diagnosed
10.86
8.34
9.74
8.96
Age
57.52
9.80
56.42
9.24
Education (yrs)
11.27
2.29
10.94
2.51
HbA1c Pre
7.71
1.33
8.43
2.13
HbA1c Post
7.62
1.56
7.96
1.79
BDI score
1.26
1.37
1.60
1.59
________________________________________________________________________

Hypothesis #1: Effects of Motivational Interviewing and Follow-up Prompt
To test Hypothesis 1 that patients receiving motivational interviewing and a
follow-up prompt (Treatment Group) would show a significant decrease in HbA1c
compared to controls, a t-test was conducted on group means of HbA1c scores at 3
months subsequent to the initial treatment contact. Although the participants were
randomly assigned the experimental or control group, Levene’s Test for Equality of
Variances suggested that the Treatment Group was significantly different from the
Control Group at baseline, t (102) = -1.07, p <.05. However, neither of the two groups
yielded a significant change three months after initial contact, with the experimental
group (N=50) showing a .09 decrease in HbA1c at three months post intervention, t (49)
= .27, p >.05 (See figure 1). The Control Group (N=57) showed a significant decrease of
.47 in HbA1c three months after enrollment in this study t (56) = 1.11, p<.05. These
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findings indicate that the intervention was unsuccessful in reducing HbA1cs for this
sample.
Hypothesis #2: Effects of Intervention and Follow-up Prompt on Pharmacy Refills
To test Hypothesis 2 that patients receiving motivational interviewing and a
follow-up prompt (Treatment Group) would obtain a higher percentage of prescription
refills compared to controls, a t-test was conducted on group means of the percentage of
refills across the 3 months of treatment (see Table 2). Of the 107 participants, 60
(56.1%) reported that they filled their medications at the EKL pharmacy. High
percentages of pharmacy prescription refills were obtained from both the treatment
(85.54%) and control (89.73%) groups. The two groups did not significantly differ in
percentage of prescription refills t (58) = .25, p >.05.
Additional Analyses
To determine the relationship between medication adherence and demographic
variables within the Treatment Group, simple, zero order correlations were computed for
demographic variables, HbA1c, and percentages of pharmacy refills. No significant
relationships were established between race, years diagnosed, sex, age, marital status,
education and employment, and HbA1c pre and post and pharmacy refills.
To test whether the group with the brief intervention and follow-up mailed
appointment reminder would yield a higher percentage of appointment attendances than
the control group, mean percentages were extracted from both the treatment (M=90.92%)
and control (M=87.62%) group (see table 2). An independent sample t-test showed that
there was no significance between the two groups in terms of percentage of appointment
attendance t (105) = .37, p >.05.
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Figure 1: Hba1c means at baseline and three months following initiation of study for
treatment and control group.
Table 2: Means for number of appointments attended versus appointments scheduled,
percentage of appointments attended, and percentages of pharmacy refills collected for
treatment and control groups.
Group

Treatment

Mean number
Mean number
Mean
of appointments of appointments percentage of
attended
scheduled
appointments
attended
2.47
2.76
90.92

Mean
percentage of
pharmacy
refills collected
85.54

Control

2.24

89.73

2.58

87.62

Reliability Between Interviews
The Motivational Interviewing Skill Code (MISC) (Miller, 2000) was used to
verify reliability between interviews. The MISC is a rigorous coding system that requires
at least three passes through a single session. Each statement made by the therapist is
then categorized by content (e.g. reflective statement, informational statement, etc.), and
frequencies of the statements are recorded. The primary “elements” of motivational
interviewing (i.e. acceptance, egalitarianism, empathy, genuineness, warmth, and spirit)
are rated on a scale from 1-7. The statement codings are reported in terms of how many
times that element is used throughout the interview (e.g. number of facilitative
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statements, number of filler statements, etc.). Approximately eleven percent of the
experimental sessions were taped and then thoroughly coded using the MISC.
Reliability for the six elements of motivational interviewing was examined using
means and standard deviations. Acceptance, warmth, and spirit yielded 100% reliability
with zero variance between ratings. The scores for empathy and genuine also provided
minimal variance with minimum ratings of 6 (M=6.67, SD=.52). The scores for
egalitarianism yielded a smaller mean (M=5.33) and larger standard deviation (SD=.82).
Regarding the statements made by the interviewer, no directive or confrontational
statements were recorded in any of the sessions. Confidence intervals were used to
assess for reliability in frequencies of interviewer statements. The structure technique
was used twice, but only in one of the interviews. For the rest of the interpretations,
confidence intervals were evaluated as rounded integers, as decimals were not used in
coding. One additional question was asked outside of the confidence interval ranges for
advice and facilitation. Two additional questions were asked in an interview concerning
providing information. Five questions beyond the higher confidence interval range were
asked in one of the interviews. In one of the interviews, zero filler statements were made,
which was below the lower confidence interval range. This was also true for the support
technique. The data suggests that for affirmation, emphasizing control, raising concern,
reflecting, reframing, and warning, all of the interviews were within the same confidence
interval range.
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DISCUSSION
This study attempted to explore the effects of a brief intervention and follow-up
prompt on HbA1c in individuals with type 2 diabetes. The goal of this study was to
determine whether a 15-minute brief intervention using the principles of motivational
interviewing would be sufficient to contribute to significant decreases in HbA1c when
paired with a mailed appointment reminder, versus usual care controls. A general
overview of the findings of the current study will be presented, followed by a discussion
of the research hypotheses, a review of the limitations of the current study, and
concluding remarks and indications for future research.
Effects of Brief Intervention and Follow-up Prompt on HbA1c
Research question #1 addressed the effects of a brief intervention and follow-up
prompt on HbA1c as compared with controls. For the Treatment Group, the initial
HbA1c was within the fair to moderate range for diabetics. Thus, to make a significant
decrease in HbA1c would be more difficult than if HbA1c were more poorly controlled.
This can be likened to a well-known principle of weight loss. For example, the more
weight an individual has to loose, the easier it often is for them to initially loose weight.
Likewise, individuals who are attempting to loose smaller amounts of weight often
struggle because they are already closer to their target range. In addition, it is the
individual with less weight to loose that is in greater short term danger of having setbacks
because recommended lifestyle changes may not be as drastic (e.g. restricting 200
calories from a 1200 calorie/day diet versus 200 calories from a 3000 calorie/day diet).
This same idea serves to explain one possible reason why the Control Group experienced
greater nonsignificant decreases in HbA1c. Again, as mentioned previously, a random
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sampling numbers table was used to delegate individuals to either the treatment or control
group, so the significant difference between the two groups remains a very unusual
finding.
Attempting to achieve significant results using participants recruited from hospital
clinic waiting rooms addresses a significant problem facing adherence researchers. The
low SES, predominantly African American population is inarguably an important
population to research, as this population is at risk for acquiring chronic disease and
dealing with related complications (Aljasem, Peyrot, Wissow, & Rubin, 2001; Apter,
Reisine, Affleck, Barrows, & Zuwallack, 1998; Brownbridge & Fielding, 1994;
Schectman, Bovbjerg, & Voss, 2002; Golin, DiMatteo, & Gelberg, 1996). When
designing interventions with this population the goal is often to increase adherence in less
adherent individuals. However, a sample taken from a hospital waiting room may be a
confound when targeting nonadherent individuals, as appointment attendance is
considered to be one indirect measure of adherence (Newell, Bowman, & Cockburn,
1999). Therefore, those individuals sampled from a waiting room are more likely than
their nonattending counterparts to have better controlled and more stabilized HbA1c
levels.
Effects of Brief Intervention and Follow-up Prompt on Pharmacy Refills
Both the treatment and control group averaged high percentages of pharmacy
refills for their diabetes medication, 85.54% and 89.73% respectively. Medication taking
for type 2 diabetics has been shown to be associated with diabetes related complications,
an identified important area for research (Bartlett, 1988; Newman, Bowman, &
Cockburn, 1999; Peck & King, 1982). However, the current study did not support such
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findings. Instead, both groups appeared to achieve sufficient levels of pharmacy refills.
However, the pharmacy data analyzed was only EKL pharmacy data. On an aside, the
researcher would like to note that at the time that the study began, the EKL pharmacy
raised its medication co-payment. Thus, several subjects reported that they used to get
their medications filled at the EKL pharmacy, but were no longer doing so due to the
raised cost. It can only be speculated that non-EKL pharmacy refill percentages might be
lower than EKL because of the effort and inconvenience associated with getting to the
pharmacy, as opposed to using the EKL pharmacy while already on the premises for
physicians’ appointments. However, pertaining to the pharmacy data for the current
study, it appears that patients that use the EKL pharmacy do not perceive medication
refills to be a barrier to diabetic adherence. These high percentages of medication refills
indicate that patients are very accurate with their current medication taking practices.
Mailed Appointment Reminders and Follow-up Prompts
The mean number of percentage of appointments attended throughout the study
period were also very high, with the Treatment Group (M=90.92%) resulting in a slightly
higher overall attendance rate, as compared with the Control Group (M=87.2). As the
difference between the groups was not significant, we are unable to conclude that the
mailed appointment reminders had any effect on appointment attendance. Other studies
have suggested that there exists a potential for these low cost reminders to yield
significant differences in appointment attendance (Glasgow & Eakin, 1998; Skaer, Sclar,
Markowski, & Won, 1993), however this hypothesis was not supported by the current
study. Once again, the sample being studied was comprised of a group of individuals that
have a history of attending appointments (at least one- the day that they were recruited),
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thus these reminders may have merely reinforced their appointment attendance, or even
have been redundant to their own procedures for remembering their appointments.
Limitations
Several issues must be considered when interpreting the data presented in the
current study. The first limitation is that this study lacked participants sufficient for a
thorough data analysis. Although 157 subjects were willing to participate in the study, 43
individuals had to be excluded because either there was no initial or no follow-up HbA1c
data.
There are three points of interest pertaining to this issue. First, nine individuals,
upon medical chart review, were identified as having attended their physician’s
appointment, but following the appointment, did not walk across the parking lot from the
clinic to the main hospital to have their lab work done. This will be discussed further in a
subsequent section. Second, at least six patients were identified through their medical
charts as not having a physician’s referral to have lab work done, and thus there were no
initial and/or follow-up HbA1c available. One participant was excluded because he had
not had lab work completed in over a year, but the physician continued to record that the
patient’s DM II was “under good control”. Lastly, for the remaining excluded
participants, it is unclear why initial and/or post HbA1c data was unavailable. This
speaks to the need for standardization of medical care, as well as the need for
interventions targeting not only appointment adherence, but also addressing the
importance for patients to have their lab work done.
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Conclusions and Implications for Future Research
In summary, it appears that the 15-minute interview with follow-up prompt failed
to produce greater medication adherence than usual care. However, there are a few
points of interest worth commenting on. Most of the existing literature is comprised of
brief interventions that include at least one follow-up intervention (Clark & Hampson,
2001; Ockene et al., 1987; Rimmer, Silverman, Braunschweig, Quinn, & Liu; Weinger,
& Jacobson, 2001). However, the results of the current study indicate that perhaps a onetime brief intervention may not be sufficient to motivate patients to make behavioral
modifications. Future one-time brief interventions may wish to investigate the effects of
a longer intervention.
Returning back to the aforementioned concept of researching the already adherent
population, the Stage of Change model suggests that over time, it is the individuals in the
contemplation stage that are going to achieve the best results (Prochaska, DiClemente, &
Norcross, 1992). As the current study recruited patients that were attending appointments
and had been diagnosed with diabetes for at least one year, it is likely that the sample was
largely comprised of individuals in the action or maintenance stage. Thus, behavioral
patterns may have been more firmly established with this population than with a sample
of individuals currently preparing for or contemplating behavior change. Future studies
may wish to examine the effects of a brief intervention on people with type 2 diabetes,
comparing individuals in preparation and contemplation with those in action and
maintenance. In addition, studies targeting nonadherent individuals, investigating current
medication taking practices and barriers to medication refills and appointment attendance
may provide significant insight for the adherence literature.
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Another surprising finding resulted from this study. It appears that in this sample,
although medication taking and appointment attendance (along with glucose monitoring,
diet, and exercise) have been areas of concentration in the literature, there may be a gap
in the research. There does not appear to be much research dedicated to the study of
HbA1c testing adherence. The findings from this study indicate that health care
providers may not be discussing the importance of having lab work done regularly with
their patients. Another possibility is that not all physicians regularly prescribe HbA1c
testing. However, one study suggested that 75% of health care providers recommend
regular HbA1c testing, compared to about 50% of those patients who actually completed
the testing (Lawler & Viviani, 1997). Regardless, barriers to HbA1c testing in the
diabetic population appear to warrant further investigation. Likewise, further studies may
wish to investigate lab attendance for individuals with type 2 diabetes in clinics where the
lab is in clinic, versus in hospital settings where the patient has to leave the clinic to have
their lab work done.
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APPENDIX A: DEMOGRAPHICS

Name:___________________

EKL#:____________________

Date of Diabetes Diagnosis:____________

Date of Birth:_______________

Sex:

Age:_____________

M

F

Marital Status: Single

Race: Caucasian

Married

Separated

African-American

Divorced

Widowed

Other:________________

Education Level:______________

Employment:

Y

N

Diabetes Medications Currently Taking: _______________________________________
_______________________________________

Place Where Diabetes Medications Are Filled:__________________________________

Frequency of Medication Administration:_____________________________
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APPENDIX B: CONSENT TO PARTICIPATE IN A RESEARCH STUDY
EKL#__________________

Full approval by IRB received______________

Title of Study:

The Impact of Brief Intervention on Adherence to Medication Regimen of Low-Income
Adults with Type II Diabetes
Performance Sites:
We expect about 140 participants to be gathered from one site. Participants will be
acquired and additional information will be gathered from Earl K. Long Hospital in
Baton Rouge, Louisiana.
Investigators Involved in This Study:
Principle Investigator: Phillip J. Brantley, PhD
(225) 763-3046
Co-Investigator:
Kathleen E. Kendra, BS
(225) 354-2008
Purpose of the Study:
The purpose of this study is to use the combination of an interview technique and a follow-up
prompt procedure in an attempt to promote greater adherence to diabetes medication regimen.
Description of the Study:
Dr Brantley will be directing this study. This study will take place over approximately three
months. The expected time for patients’ direct involvement in this study is approximately 30
minutes. The thirty minutes with the treatment group will be used to employ a motivational
technique. The control group will be asked questions about their current medication regimen.
Both groups will receive usual care from their diabetes physician.
Benefits of Participation in this Study:
No benefits are promised from your participating in this study. A potential benefit of your
participation is that increased adherence to you medication regimen will improve your current
health condition, or encourage you to think about making behavior modifications to your
adherence to you medication regimen.
Risks to the subject:
No known risks are identified as potential outcomes of your participation in this study. Medical
treatment is not made available to research participants by Earl K. Long Adult Psychology.
Should you endure medical illness or injury due to your participation in this study, you will be
referred to the appropriate medical staff.
Alternatives to Participation in the Study:
If you choose not to participate in this study at this time, there will be no alternatives offered to
you. Should you decide to participate in this study, you may withdraw at any time without
consequence.
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Subject’s Right to Privacy:
The research team will make every effort within their ability to maintain the confidentiality of the
information provided by you and a review of your medical chart. It is possible that the result of
this study will be published, however your personal information will not be made available to
anyone that is not a member of the research team for the current study.
Release of Information:
The medical records related to the study are available to both Adult Psychology and the Food and
Drug Administration.
Financial Information:
A. Participation in this study will not result in any extra charges above and beyond those
routinely incurred by other patients with diabetes
B. The costs of all drugs, visits, procedures and study related and unforeseen complications must
be met by subjects.
C. Subject Payment: None
Signatures:
This study has been discussed with me and all my questions have been answered. I understand
that additional questions regarding the study should be directed to investigators listed on page one
of this consent form. I understand that if I have questions about subjects’ rights, or other
concerns, I can contact the Chancellor of LSU Medical Center, at (504) 568-4801. I agree with
the terms above, acknowledge I have been given a copy of the consent form and agree to
participate in this study. I understand that I have not waived any of my legal rights by signing
this form.

__________________________________
Signature of Subject

______________________
Date

__________________________________
Signature of Witness

______________________
Date

The study subject has indicated to me that the subject is unable to read. I certify that I have read
this consent form to the subject and explained that by completing the signature line above the
subject has agreed to participate.

__________________________________
Signature of Reader

______________________
Date

__________________________________
Signature of Person Administering Consent

______________________
Date

__________________________________
Signature of Principal Investigator

_______________________
Date
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APPENDIX C: MANUAL FOR INCREASING PATIENTS’ ADHERENCE TO
MEDICATION REGIMEN
NAME:_____________________

EKL#:____________________

INTERVIEWER:_____________

DATE:__________________

Manual for Increasing Patients’ Adherence to Medication Regimen-Adapted
from Miller and Rollnick (1991).
Introduction:
“Taking your medications as your doctor has recommended may be one of the most
difficult parts of being a diabetic. It can be very hard to remember when to take each
dose, to make sure you have your medications with you when you need them, and to
continue taking them even when you do not feel sick. It is very easy to slowly begin
taking your medication less often and to make it seem less and less important, both in
your mind as well as in your daily routine.”
Inquire about the patient’s current attitudes and behaviors regarding
medication adherence:
“On a scale from one to ten, with one being that you never or almost never take your
medications and ten being that you always or almost always take your medications, how
would you rate your current medication taking behaviors such as taking your medications
as often as your doctor has told you to?”
“On that same scale from one to ten, how confident are you that if you decided to
improve the way you take your medications that you could do it?”

Inquire about current medication regimen:
“What is your current medication schedule?”
-When do you take them?

-How often do you refill your prescriptions?

-Where do you get your prescriptions refilled?

-How do you remind yourself to take your medications?
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Identifying challenges to medication adherence:
“What are some of the most challenging problems that you have with taking your
medications as your doctor recommends?”

Reflect:
“It sounds like some of the biggest problems you have with taking your medications
as your doctor recommends are__________, ______________, __________, etc. What
are some ways that you could think of that would make taking your medications as your
doctor has told you to less of a problem for you?” Note: if patient has trouble generating
ideas for problem solving, prompt them with one idea and attempt to get them to add
ideas of their own.
Summarize the discussion:
“It sounds like you have been having difficulty taking your medications as prescribed
partly due to ________, ___________, ________, etc. But you have also said that you
think that if you started to _____________, you would be more likely to take your
medications as your doctor has prescribed. Can you think of anything else that we just
talked about that I missed?”

“On a scale from one to ten, with one being that you never or almost never take your
medications and ten being that you always or almost always take your medications, how
confident or sure do you feel that you, based on what we have talked about, can improve
the way with which you take your medications?”
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NAME:_____________________

EKL#:____________________

INTERVIEWER:_____________

DATE:__________________

The following form is to be filled out by the motivational interviewer during their brief intervention
session with the patient. A copy of this list may be made and given to the patient at their request.

EXPLORING GOALS: In the space below, write down what the patient identifies as
their general goals. Ask them to list them in a hierarchical fashion, if possible.

Now, ask the patient how these goals are impacted by or related to their medication adherence.

DECISIONAL BALANCE: In the space below, record what the patient identifies as the pros and cons for
maintaining their current behaviors
Pros

Cons

In the space below, record what the patient identifies the pros and cons for behavior change regarding
adherence to medication regimen
Pros

Cons

PLAN OF ACTION: In the space below write down a few suggestions generated by the patient about how
they can improve their medication adherence. Prompts to use may include, e.g. what are some of the
important reasons you would make a behavior change? The first steps you plan to use to make a behavior
change are…, People that may be able to help you to change are…, and I hope that my plan will have these
positive results.
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APPENDIX D: GUIDE FOR IMPROVING MEDICATION TAKING

Why is medication taking important?
You doctor has prescribed diabetes medications to you help you control you blood sugar. The
more you take your medications as prescribed, the more well-controlled your blood sugar will be.
In other words, you will be less likely to have diabetes related problems such as blindness and
heart problems which can lead to: strokes, gangrene leading to amputations, high blood pressure,
and gum problems. Diabetic problems can also cause kidney failure and nerve damage.
Become an active participant in the management of your diabetes
In addition to taking your medications as prescribed, you will benefit from having them filled on
a regular basis. You will also benefit from attending all of your appointments at the Diabetes
Clinic to allow you doctor to help you manage your diabetes. Make sure that you fully
understand how and when you need to take your medications. Do not hesitate to ask your doctor
when something that he or she says in unclear to you.
Find strategies to help you remember to fill your prescriptions:
-Mark the date on your calendar
-Post the date on your refrigerator
-Keep a note near where you keep your medications that has the date that you need to refill your
prescriptions on it
-Be creative! Write down some of your own ideas to help you remember to refill your
prescriptions below:

Find strategies to help you remember to take your medications:
-Keep your medications somewhere that you will see them and be reminded to take them (e.g. on
your kitchen table, by your television, etc.)
-Buy a tiny alarm clock or a watch with an alarm on it, and set it to go off the next time you need
to take your medications
-Try to take your medications at the same time each day (e.g. before or during meals, when you
are getting ready for work, bed, etc.). Do not hesitate to discuss times for medication taking that
may be best for your health as well as easy for you to remember with your physician.
--Be creative! Write down some of your own ideas to help you remember to take your
medications below:

55

APPENDIX E: CONTROL INTERVIEW
NAME:_____________________

EKL#:____________________

INTERVIEWER:_____________

DATE:__________________

Introduction:
“Thank you for your willingness to participate in this study. I would like to take a
couple minutes and ask you a few questions about how you currently take you diabetes
medications.”

Inquire about current medication regimen:

“What is your current medication schedule?”
-When do you take them?

-How often do you refill your prescriptions?

-Where do you get your prescriptions refilled?
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APPENDIX F: BRIEF MOTIVATION INTERVENTION ADAPTED FROM MILLER
AND ROLLNICK

Brief Motivational Intervention Adapted from Miller and Rollnick (1991)
In their 1991 book, Miller and Rollnick state that the most influential impact of a brief
intervention is to motivate the patient to change their current maladaptive behaviors. The intent
of the principles of motivational interviewing (MI) is to provide practical utilization for assisting
people in helping others change their behavior. Not only is MI for patients who present with the
desire for change, it is also useful in promoting change or even contemplation about change in
people who have been identified as being resistant or ambivalent about change. MI asserts that
making changes is up to the individual. The role of the motivational interviewer is to use basic
strategies in persuading the patients to derive for themselves that changing their maladaptive
behaviors is in their best interest. This type of intervention is based on principals that are in stark
contrast with the historical interventions that instructs patients or uses confrontational techniques.
Miller, in 1983, outlined five basic principles that guide the motivational interview. The
first principle is the expression of empathy. Following Carl Rogers, the expression of empathy
entails showing the patient warmth, using techniques such as reflective listening and the idea of
accepting the patient without judging, blaming, or criticizing. The second strategy to be
employed is the development of discrepancy. The concept of cognitive dissonance is applicable
here. The interviewer guides the patient to the realization that the patient’s current behaviors may
be incongruent with their broader goals. It is essential that patients are able to generate this list of
incongruencies themselves, as they will be more likely to detect the discrepancies. A technique
to help them realize these discrepancies is known as the decisional balance exercise. The
decisional balance can be presented to the patient as a pro/con or cost/benefit analysis. It contains
statements that the patient made regarding their perception of their motivations to change their
possible reasons for sustaining their current behaviors.
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The third principle of motivational interviewing is to avoid argumentation. To confront
patients in an oppositional manner is counterproductive, as it is likely to make them defensive and
more resistant to change. The fourth principle, rolling with resistance, is especially applicable to
these patients. Motivational interviewers are advised to avoid providing their own opinions, but
rather, offer new perspectives. It is made clear to patients that the session is for their benefit, and
it is up to them to decide how much they wish to get out of it. Patients are encouraged to actively
work with the interviewer to problem-solve and answer their own questions and deal with their
barriers.
Lastly, the guidelines come full circle as the first and fifth principles are designed to
improve self-efficacy. Increasing the patients’ self-efficacy serves the purpose of encouraging
individuals to change by suggesting that they will be successful if they apply effort to make the
desired behavior changes. It is important that patients understand that they are responsible for
their behavior modification. Miller and Rollnick (1991) suggest that motivational interviewing
can be successfully used to assist patients who are ready to change, and to help those that may not
currently be ready to change or are in a maladaptive behavioral pattern to become “unstuck” and
to start the change process.
General Strategies:
1. Ask open-ended questions:
•

Tell me briefly about your diabetes. (Prompts: How do you feel about living with diabetes?
What are some lifestyle changes you make since you were diagnosed?)

•

Tell me about your current medication regimen.

•

What do you like about it? What are some problems you have with medication adherence?

2. Listen reflectively. Identified by Miller and Rollnick (1991) as “roadblocks”, avoid
maladaptive strategies such as ordering, warning, providing solutions, preaching, criticizing, and
shaming.
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3. Affirm. The motivational interview is designed to provide support to the patient. This can be
conveyed by using empathy and through statements of appreciation and understanding.
Examples include:
• It must be difficult to have to make so many lifestyle changes accompanying the diagnosis of
diabetes. I must say, if I were in your position, I would also find that difficult.
• It seems like you are a really strong person. I can see that adjusting to attending
appointments and relying on others for treatment would be difficult.
• Living with diabetes is not easy. I can understand how you may become frustrated with the
adjustments.
• Having to comply with a complex medication regimen is not easy. I can understand how
total adherence could seem overwhelming.
4. Summarize. This technique is to be used throughout the motivational interview. To
summarize, attempt to link together statements that have already been made. For example:
It sounds like you are worried about your ability to take your medications as directed.
You have mentioned that it is difficult for you to remember to take your medications, and that
sometimes it seems like more trouble than it is worth. What are some concerns that you have
about taking your diabetes medications?
5. Elicit Self-Motivational Statements. It is up to the patient to decide whether or not to make
behavior changes. It is also important for them to be able to identify changes to be made, and
why they think they would like to make the changes. This is called problem recognition.
Examples of desirable statements include:
•

I guess I didn’t realize before that I had a problem with medication adherence.

•

Maybe I am not as good as I could be about taking my diabetes medications.

Expression of concern is also a way that patients can communicate with the interviewer that they
are contemplating making behavior changes. Examples include:
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• I am worried about my medication adherence.
• I feel very frustrated by my diabetes/medications.
A third type of motivational statement is the intention to change. These statements can be direct
or implicit. Examples include:
• I think it’s time for me to think about taking my medications more regularly.
• I feel that I have to do something about this.
Lastly, self-motivational statements can suggest optimism about making behavior changes. This
reflects the patient’s self-efficacy. Examples include:
• I think I can do it.
• I am going to improve my medication adherence.
There are multiple ways to elicit self-motivational statements. The motivational interviewer
can ask for them directly, using open-ended questions (e.g., What makes you think there could be
a problem with your current medication taking practices?). The interviewer may also attempt to
elicit elaboration from the patient. This may encourage patients to make more self-motivational
statements. To do this, the interviewer may ask for specific examples or directly encourage the
patient to provide more details. The interviewer may also wish to use extremes to help the patient
think about the extent of the consequences of their behaviors (e.g., What are your worst fears
about what might happen if you don’t take your medications?).

Among the more active approaches for eliciting self-motivational statements are
exploring goals and creating a decisional balance. Both techniques involve the patient
listing reasons for changing as well as reasons and consequences for choosing not to
work on changing behaviors. Exploring goals involves identifying goals that are the most
important to the patient. Once goals are identified, discrepancies between the patient’s
current behavior and ideal behavior become clearer to the interviewer and the patient.
Likewise, the decisional balance, as previously discussed, allows the patient to see the
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positives and negatives for behavior change as related to adhering to diabetes education.
Lastly, the interviewer should discuss with the patient how to begin the change process.
This requires the patient and the interviewer to work together in generating a plan of
action that is realistic.
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